Created at Source Raw Value Validated value
Feb. 25, 2022, noon oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: CKD-314: CKD-314 is administered intravenously and standard of care is also performed.Dosage form: Injection 50 mg/vial.Administration route: Intravenous (IV) infusion. Frequency and duration-:The investigational product (IP) will be administered at the dose of 0.1 to 0.2 mg/kg/hr (2.4 to 4.8 mg/kg/day) by the investigator in consideration of the severity and underlying diseases of the subject.Control Intervention1: CKD-314 Placebo: CKD-314 placebo is administered intravenously and standard of care is also performed.Dosage form: Injection 50 mg/vial.Administration route: Intravenous (IV) infusion. Frequency and duration-:The investigational product (IP) will be administered at the dose of 0.1 to 0.2 mg/kg/hr (2.4 to 4.8 mg/kg/day) by the investigator in consideration of the severity and underlying diseases of the subject.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: CKD-314: CKD-314 is administered intravenously and standard of care is also performed.Dosage form: Injection 50 mg/vial.Administration route: Intravenous (IV) infusion. Frequency and duration-:The investigational product (IP) will be administered at the dose of 0.1 to 0.2 mg/kg/hr (2.4 to 4.8 mg/kg/day) by the investigator in consideration of the severity and underlying diseases of the subject.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: CKD-314 Placebo: CKD-314 placebo is administered intravenously and standard of care is also performed.Dosage form: Injection 50 mg/vial.Administration route: Intravenous (IV) infusion. Frequency and duration-:The investigational product (IP) will be administered at the dose of 0.1 to 0.2 mg/kg/hr (2.4 to 4.8 mg/kg/day) by the investigator in consideration of the severity and underlying diseases of the subject.", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 291, "treatment_name": "Ckd-314", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]